At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ODD ODDITY Tech Ltd.
Post-Mkt 08-18 16:17:20 EDT
12.30
+0.21
+1.74%
盘后12.30
+0.000.00%
16:10 EDT
High12.60Low11.97Vol816.48K
Open12.04D1 Closing12.09Amplitude5.21%
Mkt Cap567.33MTradable Cap351.61MTotal Shares46.12M
T/O10.08MT/O Rate2.86%Tradable Shares28.59M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates
Dow Jones  ·  08-06
Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals
GlobeNewswire  ·  08-06
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire  ·  08-04
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise
GlobeNewswire  ·  08-03
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise
Press Release: Radiopharm Theranostics Reports Business Update
Dow Jones  ·  07-31
Press Release: Radiopharm Theranostics Reports Business Update
ODDITY Tech Shareholders Approve All Proposals at 2026 Annual Meeting
TIPRANKS  ·  07-31
ODDITY Tech Shareholders Approve All Proposals at 2026 Annual Meeting
5 Microcap Software Stocks Expected to Soar by Triple Digits as the Companies' Sales Pop
Dow Jones  ·  07-30
5 Microcap Software Stocks Expected to Soar by Triple Digits as the Companies' Sales Pop
ODDITY to Announce Second Quarter 2026 Financial Results on September 9, 2026
GlobeNewswire  ·  07-23
ODDITY to Announce Second Quarter 2026 Financial Results on September 9, 2026
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
GlobeNewswire  ·  07-21
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
Oddity Tech CFO Lindsay Drucker Mann Disposes of USD 1.65 Million in Common Shares
Reuters  ·  07-01
Oddity Tech CFO Lindsay Drucker Mann Disposes of USD 1.65 Million in Common Shares
Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)
GlobeNewswire  ·  06-30
Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants
GlobeNewswire  ·  06-22
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
GlobeNewswire  ·  06-22
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
Oddity Tech board expands share buyback distribution up to $200 million under Israeli Companies Law
Reuters  ·  06-17
Oddity Tech board expands share buyback distribution up to $200 million under Israeli Companies Law
ODDITY Tech Sets July 29, 2026 AGM to Vote on Board, Auditor and Governance Matters
TIPRANKS  ·  06-17
ODDITY Tech Sets July 29, 2026 AGM to Vote on Board, Auditor and Governance Matters
Oddity Tech announces annual shareholder meeting
Reuters  ·  06-17
Oddity Tech announces annual shareholder meeting
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
GlobeNewswire  ·  06-15
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
Oddity Tech Unit to Repurchase $50 Million of Exchangeable Senior Notes
MT Newswires Live  ·  06-12
Oddity Tech Unit to Repurchase $50 Million of Exchangeable Senior Notes
ODDITY Tech to Repurchase $50 Million of Exchangeable Notes at Discount
TIPRANKS  ·  06-12
ODDITY Tech to Repurchase $50 Million of Exchangeable Notes at Discount
Oddity Tech: Unit Entered Into Separate, Privately Negotiated Repurchase Deals
THOMSON REUTERS  ·  06-12
Oddity Tech: Unit Entered Into Separate, Privately Negotiated Repurchase Deals

Introduction

Company Name.
ODDITY Tech Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Oddity Tech Ltd. operates as a consumer tech company that builds and scales digital-first brands to disrupt beauty and wellness industries. The company serves consumers worldwide through its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. It owns IL MAKIAGE and SpoiledChild brands. The company was incorporated in 2013 and is headquartered in Tel Aviv, Israel with additional office in New York, New York.
Issue price:
--